PRMT5 and cancer: We show that, among all cancers, PRMT5 was transcriptionally upregulated in HGSOC tumors and that this transcriptional upregulation was likely due to TP53 mutations and the impairment of homology-directed repair due to the loss of additional genes such as BRCA1/2 in these tumors.